| AAP |
American
Academy of Pediatrics |
| AAFP |
American
Academy of Family Physicians |
| AAHP |
American
Association of Health Plans |
| ACASA |
Adult
Clinic Assessment Software Application |
| ACIP |
Advisory
Committee on Immunization Practices |
| ACOG |
American
College of Obstetricians and Gynecologists |
| AFIX |
Assessment,
Feedback and Incentives Exchange |
| AIDS |
Acquired
Immune Deficiency Syndrome |
| AIRA |
American
Immunization Registry Association |
| AKC |
All
Kids Count |
| ASD |
Autism-spectrum
disorder |
| ASTPHLD |
Association
of State and Territorial Public Health
Laboratory Directors |
| ATPM |
Association
of Teachers of Preventive Medicine |
| ATSDR |
Agency
for Toxic Substances and Disease Registry |
| BCG |
Bacillus
of Calmette and Guérin (tuberculosis
vaccine) |
| BSE |
Bovine
spongiform encephalopathy |
| CASA |
Clinic
Assessment Software Application |
| CBER |
Center
for Biologics Evaluation and Research (FDA) |
| CDC |
Centers
for Disease Control and Prevention |
| CF |
Complement
fixation |
| CII |
Childhood
Immunization Initiative |
| CIRSET |
Committee
on Immunization Registry Standards
and Electronic Transactions (an
organization that is no longer in existence
as May 2006) |
| CISA |
Clinical
Immunization Safety Assessment Centers |
| CJD |
Creutzfeldt-Jakob
disease |
| CMV |
Cytomegalovirus |
| COID |
Committee
on Infectious Diseases (AAP) |
| CPHA |
Commission
on Professional and Hospital Activities |
| CRS |
Congenital
rubella syndrome |
| CSF |
Cerebrospinal
fluid |
| CSTE |
Council
of State and Territorial Epidemiologists |
| CVID |
Common
variable immune deficiency |
| DAT |
Diphtheria
antitoxin |
| DFA |
Direct
fluorescent antibody |
| DHHS |
Department
of Health and Human Services |
| DMD |
Data
Management Division |
| DoD |
Department
of Defense |
| DPT |
Replaced
by use of DTP. See DTP for description. |
| DRSP |
Drug-resistant
Streptococcus pneumonia |
| DT |
Diphtheria
and tetanus toxoids, pediatric formulation,
for children 6 weeks to 7 years of age |
| DTP |
Diphtheria
and tetanus toxoids and whole-cell pertussis
vaccine |
| DTaP |
Diphtheria
and tetanus toxoids and acellular pertussis
vaccine |
| EBV |
Epstein-Barr
virus |
| ECBT |
Every
Child By Two |
| EIA |
Enzyme
immunoassay |
| ELISA |
Enzyme-linked
immunosorbent assay |
| ELR |
Electronic
laboratory reporting |
| EPA |
Environmental
Protection Agency |
| EPO |
Epidemiology
Program Office |
| ESD |
Epidemiology
and Surveillance Division |
| FAMA |
Fluorescent
antibody to membrane antigen |
| FDA |
Food
and Drug Administration |
| GBS |
Guillain-Barre
Syndrome |
| HA |
Hemagglutinin |
| HAV |
Hepatitis
A virus |
| HBcAg |
Hepatitis
B core antigen |
| HBIG |
Hepatitis
B immune globulin |
| HBeAg |
Hepatitis
B e antigen |
| HBsAg |
Hepatitis
B surface antigen |
| HBV |
Hepatitis
B virus |
| HCFA |
Healthcare
Financing Administration |
| HCV |
Hepatitis
C virus |
| HDV |
Hepatitis
D virus (delta agent) |
| HHE |
Hypotonic,
Hyporesponsive Episode |
| HI |
Hemagglutination
inhibition |
| Hi |
Haemophilus
influenza |
| Hib |
Haemophilus
influenza type b |
| HICPAC |
Healthcare
and Infection Control Practices Advisory
Committee |
| HMO |
Health
Maintenance Organization |
| HRSA |
Health
Resources and Services Administration |
| HSCT |
Hematopoietic
Stem Cell Transplant |
| IAC |
Immunization
Action Coalition |
| IAVG |
Interagency
Vaccine Group |
| IBD |
Inflammatory
Bowel Disease |
| IDSA |
Infectious
Disease Society of America |
| IFA |
Indirect
fluorescent antibody |
| IG |
Immune
globulin |
| IgE |
Immunoglobulin
E |
| IL-4 |
Interleukin
4 |
| IL-10 |
Interleukin
10 |
| IND |
Investigational
new drug |
| IOM |
Institute
of Medicine |
| IPV |
Inactivated
poliovirus vaccine |
| IRB |
Institutional
Review Board |
| IRC |
Immunization
Registry Conference |
| ISD |
Immunization
Services Division |
| LA |
Latex
agglutination |
| LAIV |
Live,
Attenuated Influenza Vaccine |
| LIS |
Laboratory
information system |
| MCV |
Measles-containing
vaccines |
| MMR |
Measles-mumps-rubella
vaccine |
| MMWR |
Morbidity
and Mortality Weekly Report |
| MR |
Measles-rubella
vaccine |
| MS |
Multiple
Sclerosis |
| MSAEFI |
Monitoring
System for Adverse Events Following Immunization |
| NA |
Neuraminidase |
| NACIC |
National
Advisory Committee of Immunization in Canada |
| NCCLS |
National
Committee for Clinical Laboratory Standards |
| NCHS |
National
Center for Health Statistics |
| NCID |
National
Center for Infectious Diseases |
| NCRSR |
National
Congenital Rubella Syndrome Registry |
| NCVIA |
National
Childhood Vaccine Injury Act of 1986 |
| NETSS |
National
Electronic Telecommunications System for
Surveillance |
| NHANES |
National
Health and Nutrition Examination Survey |
| NHIS |
National
Health Interview Survey |
| NIC |
National
Immunization Conference |
| NIH |
National
Institutes of Health |
| NIIW |
National
Infant Immunization Week |
| NIP |
National
Immunization Program |
| NMA |
National
Medical Association |
| NNDSS |
National
Notifiable Diseases Surveillance System |
| NNii |
National
Network for Immunization Information |
| NPI |
National
Partnership for Immunization |
| NVAC |
National
Vaccine Advisory Committee |
| nvCJD |
new
variant Creutzfeldt-Jakob disease |
| NVICP |
National
Vaccine Injury Compensation Program |
| NVPO |
National
Vaccine Program Office |
| OPV |
Oral
poliovirus vaccine |
| P&I |
Pneumonia
and influenza |
| PAHO |
Pan
American Health Organization |
| PCR |
Polymerase
chain reaction |
| PCV7 |
Pneumococcal
Conjugate Vaccine (7-valent) |
| PFP |
Partnership
for Prevention |
| PHA |
Passive
hemagglutination |
| PHF |
Public
Health Foundation |
| PHLIS |
Public
Health Laboratory Information System |
| PHPPO |
Public
Health Practice Program Office |
| PHS |
Public
Health Service |
| PHTN |
Public
Health Training Network |
| PMIRWG |
Program
Managers Immunization Registry Work Group |
| PPD |
Purified
protein derivative |
| PPV23 |
Pneumococcal
Polysaccharide Vaccine (23-valent) |
| PRMA |
Pharmaceutical
Research and Manufacturers of America |
| RASH |
Rapid
Surveillance Helper |
| RET |
Reportable
Events Table |
| RIA |
Radioimmunoassay |
| RNA |
Ribonucleic
acid |
| RSD |
Residual
Seizure Disorder |
| RST |
Registry
Support Team |
| SCID |
Severe
combined immune deficiency |
| SIDS |
Sudden
Infant Death Syndrome |
| SHC |
State
health coordinator |
| SPSS |
Supplementary
Pertussis Surveillance System |
| SSPE |
Subacute,
sclerosing panencephalitis |
| Td |
Tetanus
and diphtheria toxoids, adult formulation,
for persons 7 years and older |
| Tdap |
Adolescent/adult
tetanus, diphtheria, and pertussis
(whooping cough) vaccine |
| TIG |
Tetanus
immune globulin |
| TT |
Tetanus
toxoid |
| TWG |
Technical
Working Group (Immunization Registry) |
| VAE |
Vaccine
adverse event |
| VAERS |
Vaccine
Adverse Event Reporting System |
| VAPP |
Vaccine-associated
paralytic poliomyelitis |
| vCJD |
Variant
Creutzfeldt-Jakob disease |
| VFC |
Vaccines
for Children |
| VHC |
Vaccine
Health Centers |
| VHSP |
Viral
Hepatitis Surveillance Program |
| VICP |
Vaccine
Injury Compensation Program |
| VIG |
Vaccinia immune globulin |
| VIS |
Vaccine
Information Statement |
| VISI |
Vaccine
Identification Standards Initiative |
| VPD |
Vaccine-preventable
disease |
| VRBPAC |
Vaccines
and Related Biological Products Advisory
Committee (CBER) |
| VSD |
Vaccine
Safety Datalink project |
| VZIG |
Varicella-zoster
immune globulin |
| VZV |
Varicella-zoster
virus |
| WBC |
White
blood-cell count |
| WHO |
World
Health Organization |
(exit
site)